| Impact of C-reactive protein on treatment of patients with cardiovascular disease / | Gortney, Justine Schuller ;, Sanders, Rhonda Martin | 2009-2016 | 2007.10.01 | - | |
| Use of newer anticoagulants in patients with chronic kidney disease / | Lobo, Bob L. | 2017-2026 | 2007.10.01 | - | |
| Clozapine-induced leukopenia successfully treated with lithium / | Kutscher, Eric C. et al | 2027-2031 | 2007.10.01 | - | |
| Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements / | Driscoll, David F. | 2032-2036 | 2007.10.01 | - | |
| Observations on the use of ready-to-use and point-of-care activated parenteral products in automated dispensing cabinets in U.S. hospitals / | Fanikos, John. et al | 2037-2043 | 2007.10.01 | - | |
| Formation of a primary care pharmacist practice-based research network / | Dickerson, Lori M. et al | 2044-2049 | 2007.10.01 | - | |
| Pharmacist recognition of and adherence to medication-use policies and safety practices / | Saad, Aline H. et al | 2050-2054 | 2007.10.01 | - | |
| Effect of pharmacy practice residency training on residents’ knowledge of and interest in clinical research / | Ellis, Jeffrey J. et al | 2055-2063 | 2007.10.01 | - | |
| Effect of a clinical pharmacist’s interventions on duration of antiretroviral-related errors in hospitalized patients / | Heelon, Mark. et al | 2064-2068 | 2007.10.01 | - | |
| Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations / | Fiscella, Richard G. ;, Lewis, Charles C. ;, Jensen, Michael K.; | 2069-2073 | 2007.10.01 | - | |
